2025-523846-29-00
尚未招募
1 期
A clinical trial investigating the safety and biological activity of the antibody BNT351 in adults living without and with HIV
概览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- BioNTech SE
- 入组人数
- 55
- 试验地点
- 2
概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Trial Information Desk
Scientific
BioNTech SE
研究点 (2)
Loading locations...
相似试验
招募中
1 期
A Phase I trial to establish the safety and maximum tolerated dose of high-affinity autologous BCMA-targeting CAR-T cells in patients with relapsed and refractory B-cell malignancies (CARLOTTA01)2022-502831-20-00Technische Universitat Dresden16
尚未招募
1/2 期
A long-term study to monitor the health status of people with cystic fibrosis who took part in a previous study with BI 3720931 (LenticlairTM-ON)2023-504909-37-00Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.12
尚未招募
1 期
Phase 1 clinical trial to evaluate the safety, tolerability, and pharmacokinetics of intravenous single ascending doses of IM-250 in healthy volunteers.2025-523146-27-00Innovative Molecules GmbH30
招募中
1 期
clinical trial to determine the feasibility and safety of the mesenchymal stem cells use in women over 50 years of age with urinary incontinencee2024-514833-39-00Instituto De Investigacion Sanitaria Fundacion Jimenez Diaz60
招募中
不适用
Versius Gynecology StudyNCT07289295CMR Surgical Ltd45